Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Journal Article
·
· Bioorg. Med. Chem. Lett.
The SAR of a series of tri-substituted thiophene JNK3 inhibitors is described. By optimizing both the N-aryl acetamide region of the inhibitor and the 4-position of the thiophene we obtained single digit nanomolar compounds, such as 47, which demonstrated an in vivo effect on JNK activity when dosed orally in our kainic acid mouse model as measured by phospho-c-jun reduction.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- OSTI ID:
- 1026549
- Journal Information:
- Bioorg. Med. Chem. Lett., Vol. 21, Issue (6) ; 03, 2011
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Journal Article
·
Tue Feb 28 00:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026549
+20 more
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Journal Article
·
Mon Sep 14 00:00:00 EDT 2009
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026549
+7 more
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Journal Article
·
Tue Feb 28 00:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026549
+11 more